Although the identification of a single useful cutoff point to define a low and high Ki-67 in all breast cancer patients may not be achievable, the identification of reproducible cutoffs with prognostic and predictive value in specific clinical contexts remains a worthy and active area of investigation. Here, MKI67 is linked to breast cancer.